Capnia, developer of a system used to deliver carbon dioxide to treat medical conditions, has brought in $3.1 million of a targeted $4.7 million round of rights, securities and debt financing, according to a filing with the SEC. Based in Palo Alto, Calif., the company is backed by Asset Management, Teknoinvest, Vivo Ventures, Alliance Venture and Sagamore Bioventures.